Back

Strategic Program Cancer nieuws

Medicatietest op gekweekte eierstoktumor is mogelijk

Sinds kort is het mogelijk om bij eierstokkanker uit tumorcellen van een patiënt in het lab mini-eierstoktumoren te kweken om daar medicijnen op te testen. Arts-onderzoeker Chris de Witte laat zien dat de reactie van deze mini-tumoren op geneesmiddelen vrij nauwkeurig de reactie bij deze patiënt voorspelt. Ook DNA-kenmerken van de tumor lijken medebepalend voor het behandelsucces. In de toekomst kunnen deze bevindingen mogelijk helpen om patiënten een behandeling op maat te bieden en zo de overlevingskans te vergroten.

Read more…

Improving primary care involvement in cancer care

Thesis dr. Ietje Perfors, Improving primary care involvement in cancer care

Read more…

Live from University Hall Lecture Dennis Klomp

For the first time in 384 years, an inaugural lecture will be broadcast live from the University Hall. The scoop is for Professor Dennis Klomp with his lecture, entitled "Powerful Exchange in Images".

Read more…

The RASTRIC trial: new investigator driven clinical trial started

Recently, Hugo Snippert and Hans Bos (both CMM in the UMCU) found a combination of three readily available drugs, that was effective in the lab on models of this disease. Excitingly, this month a phase I/II clinical trial based on their work has officially started. The RASTRIC trial is a first-in-human clinical trial to test this new combination. The trial is led by medical oncologist Jeanine Roodhart and is open for registration.

Read more…

Cancer mutations convert an inhibitory protein into an accelerator for tumor growth

Cancer-inhibiting proteins, so-called tumor suppressors, play an important role in the prevention of uncontrolled cell division. This prevents tumor formation; similar to a brake in a car. Researchers from the UMC Utrecht have now shown that the generation of a fragment of these proteins leads to a switch in their function, turning the brake into a gas pedal. These insights generate a better starting point for new and more precise treatments.

Read more…

New research into childhood cancer

The Princess Máxima Center and UMC Utrecht recently signed a new and promising collaboration agreement.

Read more…

Informing metastatic colorectal cancer patients by quantifying multiple scenarios

Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data

Read more…

OncoCareer Board for early-career scientists

Read more…

How Our Immune Cells Recognize And Kill Tumor Cells

Read more…

Need to know & Nice to know NEWSLETTER october 2019

Read more…